Qingdao Sino-cell Biomedicine Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2019-03-04
- Employees
- -
- Market Cap
- -
Clinical Trials
4
Active:0
Completed:0
Trial Phases
3 Phases
Early Phase 1:1
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Early Phase 1
1 (25.0%)Not Applicable
1 (25.0%)HS-IT101 Injection for Advanced NSCLC
Not Applicable
Not yet recruiting
- Conditions
- Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Qingdao Sino-Cell Biomedicine Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT07105176
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
HS-IT101 Injection in the Treatment of Advanced Melanoma
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Qingdao Sino-Cell Biomedicine Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06941818
- Locations
- 🇨🇳
Peking University Cancer Hospital, BeiJing, China
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Early Phase 1
Not yet recruiting
- Conditions
- Solid Tumor
- Interventions
- Drug: HS-IT201 Injection
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-09-25
- Lead Sponsor
- Qingdao Sino-Cell Biomedicine Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06613152
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Qingdao Sino-Cell Biomedicine Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT06342336
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
News
No news found